AQR Arbitrage’s Intersect ENT, Inc XENT Stock Holding History

AQR Arbitrage’s Portfolio XENT Stock Details XENT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-438,869	Closed	-$12.3M	–	1627
2022 Q1	$12.3M	Buy	438,869 +76,870	+21%	+$2.11M	0.32%	81
2021 Q4	$9.89M	Hold	361,999	–	–	0.25%	92
2021 Q3	$9.85M	Buy	+361,999	New	+$8.95M	0.28%	103

AQR Arbitrage's XENT Position: Q2 2022 in Review

AQR Arbitrage sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 438,869 shares — an estimated $12.3M sold.

AQR Arbitrage first reported a position in XENT in Q3 2021 and held it in 3 quarters. The position peaked at $12.3M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

AQR Arbitrage reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
AQR Arbitrage sold 438,869 Intersect ENT, Inc shares in Q2 2022, an estimated $12.3M.
AQR Arbitrage first reported a position in Intersect ENT, Inc in Q3 2021 and held it in 3 quarters.
AQR Arbitrage's Intersect ENT, Inc position peaked at $12.3M in Q1 2022.
0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on AQR Arbitrage's 13F filing for Q2 2022, filed 15 Aug 2022.